Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Surgical Wound Infection 4Colorectal Neoplasms 4Rectal Neoplasms 2Pancreatic Neoplasms 2Pancreatic Fistula 1Intestinal Neoplasms 1Exanthema 1Duodenal Neoplasms 1Diarrhea 1Colonic Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Irinotecan 8Bevacizumab 8Fluorouracil 7Leucovorin 6Oxaliplatin 5Capecitabine 4Drug Therapy 3Cetuximab 35,10-methylenetetrahydrofolic acid 3Radiotherapy 2Levoleucovorin 2Folfox protocol 2Colonoscopy 2Aspirin 2trametinib 1spartalizumab 1repotrectinib 1pralsetinib 1pembrolizumab 1nazartinib 1napabucasin 1lutetium Lu 177 dotatate 1guadecitabine 1encorafenib 1copper dotatate CU-64 1canakinumab 1camrelizumab 1apatinib 1alectinib 1aldesleukin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Intestinal Neoplasms × Anti-Bacterial Agents × Gastrointestinal × Clear all
NCT03563586 2020-09-11

MECCA

National and Kapodistrian University of Athens

Phase NA Unknown
210 enrolled
Gastrointestinal

Intestinal Neoplasms, Surgical Wound Infection, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡